Treatment of Intervertebral Disc Degeneration.
Xin J, Wang Y, Zheng Z, Wang S, Na S, Zhang S.
Orthop Surg. 2022 Jul;14(7):1271-1280. doi: 10.1111/os.13254. Epub 2022 Apr 29.
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z, Song Q, Yu Y, Liu F, Zhao J, Un W, Da X, Xu C, Yao Y, Wang QK.
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):978-991. doi: 10.1002/jcsm.13179. Epub 2023 Jan 25.
[Understanding and treatment strategy for disc displacement of temporomandibular disorders].
Ma XC.
Zhonghua Kou Qiang Yi Xue Za Zhi. 2017 Mar 9;52(3):139-142. doi: 10.3760/cma.j.issn.1002-0098.2017.03.002.
Salubrinal alleviates cartilage degradation in a rabbit temporomandibular joint osteoarthritis model.
Xu T, Shuai J, Gu Z, Wu M.
Oral Dis. 2024 May;30(4):2453-2462. doi: 10.1111/odi.14731. Epub 2023 Sep 3.
Can extracellular vesicles be considered as a potential frontier in the treatment of intervertebral disc disease?
Zhu S, Wang J, Suo M, Huang H, Liu X, Wang J, Li Z.
Ageing Res Rev. 2023 Dec;92:102094. doi: 10.1016/j.arr.2023.102094. Epub 2023 Oct 18.
Mechanics- and Behavior-Related Temporomandibular Joint Differences.
Nickel JC, Gonzalez YM, Liu Y, Liu H, Gallo LM, Iwasaki LR.
J Dent Res. 2024 Sep 14:220345241265670. doi: 10.1177/00220345241265670. Online ahead of print.
Molecular therapy of the intervertebral disc.
Yoon ST.
Spine J. 2005 Nov-Dec;5(6 Suppl):280S-286S. doi: 10.1016/j.spinee.2005.02.017.
The cell biology of intervertebral disc aging and degeneration.
Zhao CQ, Wang LM, Jiang LS, Dai LY.
Ageing Res Rev. 2007 Oct;6(3):247-61. doi: 10.1016/j.arr.2007.08.001. Epub 2007 Aug 10.
Molecular biology of degenerative disc disease.
Guiot BH, Fessler RG.
Neurosurgery. 2000 Nov;47(5):1034-40. doi: 10.1097/00006123-200011000-00003.
Growth factors and treatment of intervertebral disc degeneration.
Masuda K, Oegema TR Jr, An HS.
Spine (Phila Pa 1976). 2004 Dec 1;29(23):2757-69. doi: 10.1097/01.brs.0000146048.14946.af.
